• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Clinical investigation >Fesoterodine fumarate for the treatment of overactive bladder in the elderly - a review of the latest clinical data
【24h】

Fesoterodine fumarate for the treatment of overactive bladder in the elderly - a review of the latest clinical data

机译：非索罗定富马酸酯治疗老年人膀胱过度活动症-最新临床数据回顾

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Overactive bladder is a common and troublesome condition for many older people. Although the first-line treatment for the condition is with behavioral and lifestyle measures, many older people will require pharmacological therapy to successfully manage their condition. Fesoterodine, a relatively new antimuscarinic agent for the treatment of overactive bladder, has been extensively trialed in older people and is associated with a significant improvement in both disease related outcomes and in quality of life. Fesoterodine also appears to be well tolerated in this older group of patients. This review discusses the available evidence for fesoterodine in older people to date.
机译：对于许多老年人来说，膀胱过度活动是一种常见且麻烦的状况。尽管针对该疾病的一线治疗方法是采取行为和生活方式措施，但许多老年人仍需要药物治疗才能成功治疗其疾病。非索罗定是一种相对较新的抗毒蕈碱药物，用于治疗膀胱过度活动症，已在老年人中进行了广泛试验，并与疾病相关的预后和生活质量显着改善有关。非索罗定在该较老的患者组中似乎也被很好地耐受。这篇综述讨论了迄今为止老年人中非索罗定的可用证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号